About Choksi Imaging
Choksi Imaging is a publicly listed company based in Mumbai (India) founded in 1992. Analog x-ray films are manufactured and supplied by Choksi Imaging. The company has 4 employees. Its chief executive, as recorded, is Gaurav Choksi. Its Indian entity Choksi Asia Limited reported revenue of ₹50.71 Cr. Choksi Imaging offers products and services including Ultrasound Systems and X-ray Films and Chemicals. Its focus areas include Medical Device Distributors.
Company details
Choksi Imaging was established in 1992 in Mumbai, India. Operations focus on the medical imaging sector, where analog x-ray films are produced and distributed to healthcare providers. The company maintains its headquarters in Mumbai, supporting supply chains within India and potentially beyond. Key leadership includes Gaurav Choksi as CEO. Activities remain centered on traditional film-based diagnostic solutions.
- Headquarters Mumbai, India
- Employees 4
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website choksiworld.com
- Social LinkedIn
- Legal Name Choksi Asia Ltd
- Market Cap₹121 Cr
CHOKSI · BSE
- Share Price₹217.70
+2.76% today
- Revenue₹49.31 Cr
FY 2025-26 · +33.3% YoY
- EBITDA₹6.79 Cr
Margin 13.8%
- Net Profit₹5.33 Cr
FY 2025-26 · +71.4% YoY
- P/E (TTM)23.1x
P/B 3.3x
- ROE15.6%
ROCE 18.5%
- Debt / Equity0.08
Interest cover 6.4x
- Employee Count4
Associated legal entities of Choksi Imaging
Choksi Imaging operates through Choksi Asia Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Choksi Asia Limited Listed CIN L71200MH1992PLC388063 | Active | 01 Oct 1992 | Mumbai, Maharashtra | ₹50.7 Cr | 4 | 6 | View details |
Products & Services of Choksi Imaging
Choksi Imaging offers a comprehensive portfolio of products and services, including Ultrasound Systems and X-ray Films and Chemicals.
Ultrasound and Color Doppler systems are supplied for general imaging in medical settings.
X-ray films and chemicals are provided for general radiology with a focus on quality and durability.
Board of directors of Choksi Asia Limited (Choksi Imaging)
Choksi Asia Limited is the primary company behind Choksi Imaging. The board of Choksi Asia Limited currently have 6 directors; the longest-serving is Samir Kanubhai Choksi, appointed in 2022. 17 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Samir Kanubhai Choksi DIN 00049416 | Managing Director | 12 Feb 2022 | 4 yrs 8 mo | Choksi Asia Limited |
| Brijal Mitesh Desai DIN 09839898 | Director | 06 Jan 2023 | 3 yrs 10 mo | Choksi Asia Limited |
| Jay Samir Choksi DIN 07151509 | CFO | 02 Feb 2023 | 3 yrs 9 mo | Choksi Asia Limited |
| Krishnakumar Ramanlal Parikh DIN 01177215 | Director | 01 Sep 2024 | 2 yrs 2 mo | Choksi Asia Limited |
| Shraddha Prajit Gandhi DIN 10808129 | Director | 14 Nov 2024 | 1 yr 11 mo | Choksi Asia Limited |
| Tushar Madhuvandas Parikh DIN 00049287 | Director | 12 Aug 2025 | 1 yr 2 mo | Choksi Asia Limited |
People of Choksi Imaging
1 people are tracked at Choksi Imaging (1 in leadership); the tracked headcount is 4.
| Name | Role | Group |
|---|---|---|
| CEO | Leadership |
Complete people profiles for Choksi Imaging
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Choksi Imaging
Choksi Imaging is a publicly listed company on the BSE with ticker symbol CHOKSI in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date06 May 1995
- Listed onBSE: 530427
- Listed entityChoksi Asia Ltd
- Exchange sectorHealth technology
- ISININE865B01016
- Share price₹211.35 (+1.71% on the day) · 2026-10-14
- Market capitalisation₹118 Cr
- Price to earnings23.2
- EPS (diluted, trailing year)₹9.10
- Volume (last session)103
Financials of Choksi Imaging
Exchange-reported figures of Choksi Asia Limited, the listed company behind Choksi Imaging (BSE: CHOKSI).
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 49.31 | 36.98 | 15.99 | 0.77 | 2.46 | 11.16 | 16.00 |
| Revenue growth | +33.3% | +131.3% | +1976.6% | -68.7% | -78.0% | -30.3% | - |
| EBITDA | 6.79 | 3.81 | (0.02) | (1.44) | (1.47) | (1.69) | (1.41) |
| EBITDA margin | +13.8% | +10.3% | -0.1% | -187.0% | -59.8% | -15.1% | -8.8% |
| Profit before tax | 7.50 | 4.73 | 1.50 | (0.44) | (0.50) | 2.70 | (0.52) |
| Net profit | 5.33 | 3.11 | 1.39 | (0.47) | (0.44) | 1.91 | (0.55) |
| Net profit margin | +10.8% | +8.4% | +8.7% | -61.0% | -17.9% | +17.1% | -3.4% |
| EPS (₹) | 9.36 | 5.44 | 2.43 | (1.22) | (1.08) | 4.89 | (1.42) |
| Balance sheet | |||||||
| Total assets | 44.03 | 41.65 | 37.28 | 15.52 | 15.99 | 17.43 | 15.52 |
| Net worth | 42.11 | 36.88 | 33.46 | 15.52 | 15.99 | 17.43 | 15.52 |
| Total debt | 1.92 | 4.77 | 3.82 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash & bank | 6.57 | 10.02 | 11.79 | 4.14 | 3.31 | 7.33 | 8.18 |
| Net working capital | 26.38 | 25.85 | 20.01 | 9.11 | 5.88 | 9.69 | 0.36 |
| Cash flow | |||||||
| Cash from operations | 0.74 | (2.87) | 2.68 | (2.52) | (0.56) | (2.82) | (2.52) |
| Cash from investing | 0.20 | 0.63 | 1.52 | 3.35 | (2.49) | 1.96 | (0.01) |
| Cash from financing | (3.40) | (1.20) | 0.47 | 0.00 | (0.98) | 0.00 | (0.24) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.22 | 11.86 | 12.26 | 13.29 | 11.90 | 12.15 | 8.67 | 8.42 |
| Revenue growth (YoY) | -22.5% | -2.4% | +41.4% | +57.8% | +768.6% | - | - | - |
| Other income | 0.29 | 0.31 | 0.52 | 0.29 | 0.29 | 0.23 | 0.82 | 0.24 |
| Total expenses | 7.84 | 9.86 | 10.47 | 11.69 | 10.51 | 10.90 | 8.96 | 7.45 |
| EBITDA | 1.38 | 2.00 | 1.79 | 1.60 | 1.39 | 1.25 | (0.29) | 0.97 |
| EBITDA margin | +15.0% | +16.9% | +14.6% | +12.0% | +11.7% | +10.3% | -3.3% | +11.5% |
| Depreciation | 0.09 | 0.07 | 0.05 | 0.08 | 0.06 | 0.04 | 0.05 | 0.04 |
| Interest | 0.04 | 0.09 | 0.09 | 0.14 | 0.10 | 0.09 | 0.12 | 0.13 |
| Profit before tax | 1.54 | 2.15 | 2.17 | 1.67 | 1.52 | 1.35 | 0.36 | 1.04 |
| Tax | 0.58 | 1.40 | 0.03 | 0.32 | 0.44 | 0.63 | 0.15 | 0.38 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.22 | 11.86 | 12.26 | 13.29 | 11.90 | 12.15 | 8.67 | 8.42 |
| Revenue growth (YoY) | -22.5% | -2.4% | +41.4% | +57.8% | +768.6% | - | - | - |
| Other income | 0.29 | 0.31 | 0.52 | 0.29 | 0.29 | 0.23 | 0.82 | 0.24 |
| Total expenses | 7.84 | 9.86 | 10.47 | 11.69 | 10.51 | 10.90 | 8.96 | 7.45 |
| EBITDA | 1.38 | 2.00 | 1.79 | 1.60 | 1.39 | 1.25 | (0.29) | 0.97 |
| EBITDA margin | +15.0% | +16.9% | +14.6% | +12.0% | +11.7% | +10.3% | -3.3% | +11.5% |
| Depreciation | 0.09 | 0.07 | 0.05 | 0.08 | 0.06 | 0.04 | 0.05 | 0.04 |
| Interest | 0.04 | 0.09 | 0.09 | 0.14 | 0.10 | 0.09 | 0.12 | 0.13 |
| Profit before tax | 1.54 | 2.15 | 2.17 | 1.67 | 1.52 | 1.35 | 0.36 | 1.04 |
| Tax | 0.58 | 1.40 | 0.03 | 0.32 | 0.44 | 0.63 | 0.15 | 0.38 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 49.31 | 36.98 | 15.99 | 0.77 | 2.46 | 11.16 | 16.00 |
| Revenue growth | +33.3% | +131.3% | +1976.6% | -68.7% | -78.0% | -30.3% | - |
| Other income | 1.40 | 1.58 | 2.10 | 1.16 | 1.14 | 4.58 | 1.06 |
| Total expenses | 42.52 | 33.17 | 16.01 | 2.21 | 3.93 | 12.85 | 17.41 |
| Employee cost | 1.35 | 1.07 | 1.17 | 0.31 | 0.94 | 1.33 | 1.67 |
| EBITDA | 6.79 | 3.81 | (0.02) | (1.44) | (1.47) | (1.69) | (1.41) |
| EBITDA margin | +13.8% | +10.3% | -0.1% | -187.0% | -59.8% | -15.1% | -8.8% |
| Depreciation | 0.27 | 0.18 | 0.18 | 0.16 | 0.17 | 0.19 | 0.17 |
| Interest | 0.42 | 0.48 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 7.50 | 4.73 | 1.50 | (0.44) | (0.50) | 2.70 | (0.52) |
| Tax | 2.17 | 1.62 | 0.11 | 0.03 | (0.06) | 0.79 | 0.03 |
| Net profit | 5.33 | 3.11 | 1.39 | (0.47) | (0.44) | 1.91 | (0.55) |
| Net profit margin | +10.8% | +8.4% | +8.7% | -61.0% | -17.9% | +17.1% | -3.4% |
| EPS (₹) | 9.36 | 5.44 | 2.43 | (1.22) | (1.08) | 4.89 | (1.42) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 11.09 | 11.09 | 11.09 | 3.90 | 3.90 | 3.90 | 3.90 |
| Reserves & surplus | 31.02 | 25.79 | 22.37 | 11.62 | 12.09 | 13.53 | 11.62 |
| Shareholders' funds (net worth) | 42.11 | 36.88 | 33.46 | 15.52 | 15.99 | 17.43 | 15.52 |
| Secured loans | 0.30 | 3.02 | 1.35 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 1.62 | 1.75 | 2.47 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total debt | 1.92 | 4.77 | 3.82 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total liabilities | 44.03 | 41.65 | 37.28 | 15.52 | 15.99 | 17.43 | 15.52 |
| Assets | |||||||
| Gross block | 17.96 | 16.88 | 16.15 | 6.75 | 6.75 | 6.76 | 7.92 |
| Net block | 16.39 | 15.57 | 14.95 | 5.79 | 5.95 | 6.12 | 7.34 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 3.35 | 0.78 | 6.87 |
| Inventories | 9.17 | 8.86 | 5.42 | 2.70 | 0.34 | 0.90 | 3.88 |
| Sundry debtors | 9.46 | 8.33 | 3.58 | 0.38 | 0.60 | 1.00 | 4.72 |
| Cash & bank balances | 6.57 | 10.02 | 11.79 | 4.14 | 3.31 | 7.33 | 8.18 |
| Loans & advances | 3.83 | 3.48 | 3.04 | 3.21 | 2.87 | 3.02 | 2.98 |
| Total current assets | 29.03 | 30.69 | 23.83 | 10.43 | 7.12 | 12.25 | 19.76 |
| Total current liabilities | 2.65 | 4.84 | 3.82 | 1.32 | 1.24 | 2.56 | 19.40 |
| Net working capital | 26.38 | 25.85 | 20.01 | 9.11 | 5.88 | 9.69 | 0.36 |
| Total assets | 44.03 | 41.65 | 37.28 | 15.52 | 15.99 | 17.43 | 15.52 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 10.02 | 10.43 | 5.76 | 3.31 | 7.33 | 8.18 | 10.95 |
| Net cash from operating activities | 0.74 | (2.87) | 2.68 | (2.52) | (0.56) | (2.82) | (2.52) |
| Net cash from investing activities | 0.20 | 0.63 | 1.52 | 3.35 | (2.49) | 1.96 | (0.01) |
| Net cash from financing activities | (3.40) | (1.20) | 0.47 | 0.00 | (0.98) | 0.00 | (0.24) |
| Net change in cash | (2.46) | (3.43) | 4.67 | 0.83 | (4.02) | (0.85) | (2.77) |
| Closing cash | 6.57 | 10.02 | 11.79 | 4.14 | 3.31 | 7.33 | 8.18 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +33.3% | +131.3% | +1976.6% | -68.7% | -78.0% | -30.3% | - |
| EBITDA growth | +78.2% | - | +98.6% | +2.0% | +13.0% | -19.9% | - |
| PBT growth | +58.6% | +215.3% | +9998.0% | +12.0% | - | +9998.0% | - |
| Net income growth | +71.4% | +123.7% | +395.7% | -6.8% | -123.0% | +447.3% | - |
| Revenue CAGR (3Y) | +300.1% | +146.8% | +12.7% | -63.6% | -47.8% | -21.5% | -16.3% |
| EBITDA CAGR (3Y) | - | - | -77.2% | +0.7% | +50.6% | - | - |
| Profitability & leverage | |||||||
| Net income margin | +10.8% | +8.4% | +8.7% | -61.0% | -17.9% | +17.1% | -3.4% |
| Return on capital employed | +18.5% | +13.2% | +7.2% | -2.9% | -2.9% | +16.5% | -3.4% |
| Return on net worth | +15.6% | +10.4% | +6.4% | -3.1% | -2.5% | +11.6% | -3.5% |
| Debt / equity | 0.08 | 0.12 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-term debt / equity | 0.04 | 0.06 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 6.44 | 13.22 | -200.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 2.83 | 2.24 | 1.40 | 0.11 | 0.36 | 1.52 | 2.02 |
| Inventory turnover | 5.47 | 5.18 | 3.94 | 0.51 | 3.97 | 4.67 | 3.31 |
| Debtors turnover | 5.54 | 6.21 | 8.08 | 1.57 | 3.08 | 3.90 | 3.32 |
| EPS (₹) | 9.36 | 5.44 | 2.43 | (1.22) | (1.08) | 4.89 | (1.42) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.50 | 0.00 |
| Book value per share (₹) | 64.40 | 55.24 | 49.23 | 39.79 | 41.01 | 44.69 | 39.80 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Choksi Imaging
Complete news archive for Choksi Imaging
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Choksi Imaging
Choksi Imaging was founded in 1992.
Choksi Imaging is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Gaurav Choksi is the CEO of Choksi Imaging, as recorded in our data.
Choksi Imaging has 4 employees.
The primary company behind Choksi Imaging, Choksi Asia Limited, reported revenue of ₹50.71 Cr for FY 2026, up 33% year on year.
Choksi Imaging was established in 1992 in Mumbai, India. Operations focus on the medical imaging sector, where analog x-ray films are produced and distributed to healthcare providers. The company maintains its headquarters in Mumbai, supporting supply chains within India and potentially beyond. Key leadership includes Gaurav Choksi as CEO. Activities remain centered on traditional film-based diagnostic solutions.
Choksi Imaging offers Ultrasound Systems and X-ray Films and Chemicals.
Yes, Choksi Imaging is publicly traded on BSE under the ticker symbol CHOKSI.
Choksi Imaging operates through Choksi Asia Limited.
The legal entities of Choksi Imaging currently have 6 directors, including Tushar Madhuvandas Parikh, Samir Kanubhai Choksi, Jay Samir Choksi and others.